Fri, November 19, 2021
Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021
Mon, November 15, 2021
Fri, November 12, 2021
Thu, November 11, 2021

Judah Frommer Maintained (ATAI) at Buy with Decreased Target to $24 on, Nov 16th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-24-on-nov-16th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Judah Frommer of Credit Suisse, Maintained "Atai Life Sciences N.V." (ATAI) at Buy with Decreased Target from $25 to $24 on, Nov 16th, 2021.

Judah has made no other calls on ATAI in the last 4 months.



There are 4 other peers that have a rating on ATAI. Out of the 4 peers that are also analyzing ATAI, 0 agree with Judah's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Judah


  • Elemer Piros of "Roth Capital" Initiated at Strong Buy and Held Target at $32 on, Thursday, November 11th, 2021
  • Patrick Trucchio of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $40 on, Monday, October 18th, 2021
  • Andrew Tsai of "Jefferies" Initiated at Strong Buy and Held Target at $27 on, Wednesday, September 1st, 2021
  • Nathan Weinstein of "Argus Research" Maintained at Strong Buy with Increased Target to $27 on, Tuesday, August 17th, 2021

Publication Contributing Sources